Neurofibromatosis, type 2, (NF-2) is a rare inherited disorder characterized by the development of benign tumors on both auditory nerves (acoustic neuromas). The disease is also ... more about Neurofibromatosis-2.
Neurofibromatosis-2: Genetic disorder often leading to tumors on nerves.
More detailed information about the symptoms,
causes, and treatments of Neurofibromatosis-2 is available below.
Symptoms of Neurofibromatosis-2
See full list of 35
symptoms of Neurofibromatosis-2
Treatments for Neurofibromatosis-2
Read more about treatments for Neurofibromatosis-2
Home Diagnostic Testing
Home medical testing related to Neurofibromatosis-2:
- Colon & Rectal Cancer: Home Testing
- Ear Infections: Home Testing:
Wrongly Diagnosed with Neurofibromatosis-2?
Read more about Deaths and Neurofibromatosis-2.
Diagnostic Tests for Neurofibromatosis-2
Read more about tests for Neurofibromatosis-2
Review possible medical complications related to Neurofibromatosis-2:
- Bilateral acoustic neurinoma (type of Acoustic neuroma)
- Bilateral eighth nerve tumors
- Multiple head tumors (see Head symptoms)
- Tumors of cranial nerves - these can lead to various different affects, depending on what nerve is affected.
- more complications...»
Causes of Neurofibromatosis-2
Read more about causes of Neurofibromatosis-2.
Disease Topics Related To Neurofibromatosis-2
Research the causes of these diseases that are similar to, or related to, Neurofibromatosis-2:
Neurofibromatosis-2: Undiagnosed Conditions
Commonly undiagnosed diseases in related medical categories:
Misdiagnosis and Neurofibromatosis-2
Undiagnosed stroke leads to misdiagnosed aphasia: BBC News UK reported on a man who
had been institutionalized and treated for mental illness
because he suffered from sudden inability to...read more »
Dementia may be a drug interaction: A common scenario in aged care is for
a patient to show mental decline to dementia.
Whereas this can, of course, occur due to various medical conditions,
such as a stroke or Alzheimer's disease,...read more »
Spitz nevi misdiagnosed as dangerous melanoma skin cancer: One possible misdiagnosis to
consider in lieu of melanoma is spitz nevi.
See melanoma and spitz nevi....read more »
Mild traumatic brain injury often remains undiagnosed: Although the symptoms
of severe brain injury are hard to miss,
it is less clear for milder injuries, or even those...read more »
MTBI misdiagnosed as balance problem: When a person has symptoms
such as vertigo or dizziness, a diagnosis of brain injury may go overlooked...read more »
Brain pressure condition often misdiagnosed as dementia: A condition
that results from an excessive pressure of CSF within the brain is often misdiagnosed.
It may be...read more »
Post-concussive brain injury often misdiagnosed: A study found that soldiers who had
suffered a concussive injury in battle often were...read more »
Children with migraine often misdiagnosed: A migraine often fails to be
correctly diagnosed in pediatric patients.
These patients are not the typical migraine sufferers, but migraines can also occur...read more »
Vitamin B12 deficiency under-diagnosed: The condition of Vitamin B12 deficiency
is a possible misdiagnosis of various conditions, such as multiple sclerosis (see symptoms of multiple sclerosis).
See ...read more »
Read more about Misdiagnosis and Neurofibromatosis-2
Neurofibromatosis-2: Research Doctors & Specialists
Research related physicians and medical specialists:
- Nerve Specialists:
- Cancer Specialists:
- Ear, Nose & Throat Specialists:
- Neurology (Brain/CNS Specialists):
- more specialists...»
Other doctor, physician and specialist research services:
Hospitals & Clinics: Neurofibromatosis-2
Research quality ratings and patient safety measures
for medical facilities in specialties related to Neurofibromatosis-2:
Hospital & Clinic quality ratings »
Choosing the Best Hospital:
More general information, not necessarily in relation to Neurofibromatosis-2,
on hospital performance and surgical care quality:
Neurofibromatosis-2: Rare Types
Rare types of diseases and disorders in related medical categories:
More Neurofibromatosis-2 animations & videos
Research about Neurofibromatosis-2
Visit our research pages for current research about Neurofibromatosis-2 treatments.
Clinical Trials for Neurofibromatosis-2
The US based website ClinicalTrials.gov lists information on both federally
and privately supported clinical trials using human volunteers.
Some of the clinical trials listed on ClinicalTrials.gov for Neurofibromatosis-2 include:
Read more about Clinical Trials for Neurofibromatosis-2
Statistics for Neurofibromatosis-2
Neurofibromatosis-2: Broader Related Topics
Types of Neurofibromatosis-2
Neurofibromatosis-2 Message Boards
Related forums and medical stories:
User Interactive Forums
Read about other experiences, ask a question about Neurofibromatosis-2, or answer someone else's question, on our message boards:
Article Excerpts about Neurofibromatosis-2
Neurofibromatosis, type 2, (NF-2) is a rare inherited disorder characterized by the development of benign tumors on both auditory nerves (acoustic neuromas). The disease is also characterized by the development of malignant central nervous system tumors as well.
(Source: Genes and Disease by the National Center for Biotechnology)
Definitions of Neurofibromatosis-2:
An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.
- (Source - Diseases Database)
Neurofibromatosis-2 is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Neurofibromatosis-2, or a subtype of Neurofibromatosis-2,
affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)
Ophanet, a consortium of European partners,
currently defines a condition rare when it affects 1 person per 2,000.
They list Neurofibromatosis-2 as a "rare disease".
Source - Orphanet
Contents for Neurofibromatosis-2:
User Surveys and Discussion Forums